Glimepiride 1 mg + Pioglitazone 15 mg + Metformin 500 mg Tablets – Glumight PM1 Tablets

Glumight PM1 Tablets
Composition: Glimepiride, Pioglitazone, Metformin, Hydrochloride Tablets

Glumight PM1 Tablets — Glimepiride, Pioglitazone/Metformin, Hydrochloride Tablets is used for the management of type 2 diabetes mellitus. Glimepiride helps increase insulin release, pioglitazone improves insulin sensitivity, and metformin reduces excess glucose production in the liver. Together, they provide better blood sugar control, improve glycemic balance, and help lower the risk of diabetes-related complications when taken regularly with proper diet and lifestyle changes.

Glimepiride 1 mg + Pioglitazone 15 mg + Metformin 500 mg – Glumight PM1 Tablets: Triple Therapy for Comprehensive Type 2 Diabetes Management

Active Ingredients:

• Glimepiride — Sulfonylurea
• Pioglitazone — Thiazolidinedione
• Metformin Hydrochloride — Biguanide

Therapeutic Benefits: Formulated for effective control of type 2 diabetes mellitus, this triple combination helps lower blood glucose by improving insulin secretion, enhancing insulin sensitivity, and reducing excess glucose production. Supports better control of both fasting and post-meal sugar levels.
Better Tolerability: Balanced multi-drug therapy is designed for consistent glycaemic control with good tolerability when used under medical supervision.
Mode of Action: Glimepiride stimulates insulin release from pancreatic beta cells, Pioglitazone improves insulin sensitivity in peripheral tissues, and Metformin reduces hepatic glucose production—together delivering comprehensive and sustained blood glucose management.

Can be prescribed by:

• Diabetologists
• Endocrinologists
• General Physicians.
• Healthcare practitioner

Disclaimer: To be used strictly under the guidance of a qualified healthcare professional. For prescription use only. Not intended for public marketing or promotion only.